The Parkinsons disease associated Leucine-rich repeat kinase 2 affects expression of Transferrin receptor 1 and phosphorylation of key signaling proteins in human iPSC-derived dopaminergic neurons
Funk, N.; Knab, F.; Munz, M.; Ott, T.; Gasser, T.; Biskup, S.
Show abstract
Several variants in the Leucine-rich repeat kinase 2 (LRRK2) gene account for familiar and sporadic late-onset Parkinsons disease (PD). LRRK2 is a large, multifunctional kinase involved in different intracellular pathways crucial for homeostasis and cell survival. One of the poorly understood mechanisms of Parkinsonism is the iron accumulation in Substantia nigra pars compacta (SNc). Transferrin receptor 1 (TfR) plays a significant role for iron uptake into the cell. Here, we investigated the expression of TfR in human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (hDANs) generated from PD patients carrying the LRRK2 p.G2019S form and found dysregulated TfR levels. In addition, we found gene status depending variations of LRRK2 expression in differentiated hDANs, while neuronal progenitor cells (NPCs) did not display these changes. This suggests an unknown regulatory mechanism of LRRK2 expression during dopaminergic differentiation. Further investigations showed dysregulated phosphorylation of the PD-associated GSK-3{beta} und the key signaling factor Akt.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Bioenergetic and Protein Processing Imbalances Synergize in iPSC-Dopamine neurons from Individuals with Idiopathic Parkinsons Disease 97%
- Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease 95%
- Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats 95%
Similar papers in this journal
- Live cell imaging of single neurotrophin receptor molecules on human neuron in Alzheimer's disease 96%
- Transcriptional and Histone acetylation changes associated with CRE elements expose key factors governing the regulatory circuit in early stage of Huntington's disease models. 95%
- Neuronal Dot1l is a broad mitochondrial gene-repressor associated with human brain aging via H3K79 hypermethylation 95%
Similar papers in this journal
- UBA52 is crucial in HSP90 ubiquitylation and neurodegenerative signaling during early phase of Parkinson disease 96%
- Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with alpha-Synucleinopathy 95%
- Long-term dynamic changes of NMDA receptors following an excitotoxic challenge 93%
Similar papers in this journal
- Dopamine and cortical iPSC-derived neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction: implications for protein deposition versus selective cell loss 96%
- The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson's disease 95%
- High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor that rescuespathological phenotypes in a Patient-Derived Model of Parkinson's Disease 95%
Similar papers in this journal
- Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein 96%
- Lysosomal perturbations in dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation 95%
- Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.